MTOR Inhibitor-Based Combination Therapies for Pancreatic Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2017.421
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Molecular Targeted Therapies for Pancreatic Cancer

American Journal of Surgery
MedicineSurgery
2008English

Targeted Therapies for Pancreatic Cancer and Hurdles Ahead

Anticancer Research
MedicineCancer ResearchOncology
2018English

Pd32-09 Combination Effect of Therapies Targeting the Pi3k-Mtor and Ar Signaling Pathways in Prostate Cancer

Journal of Urology
Urology
2016English

GEMMs as Preclinical Models for Testing Pancreatic Cancer Therapies

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2015English

Methods for Monitoring Artemisinin-Based Combination Therapies Efficacy

Clinical Reviews and Opinions
2017English

Synergistic Activities of MET/RON Inhibitor BMS-777607 and mTOR Inhibitor AZD8055 to Polyploid Cells Derived From Pancreatic Cancer and Cancer Stem Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Stem Cell–directed Therapies in Pancreatic Cancer

Current Problems in Cancer
Cancer ResearchOncology
2013English

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Gastroenterology
HepatologyGastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy